NasdaqCM - Delayed Quote USD
NRx Pharmaceuticals, Inc. (NRXPW)
0.0890
-0.0150
(-14.42%)
At close: June 13 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 2 | 3 |
Avg. Estimate | -- | 13.5M | 68.6M | 107.58M |
Low Estimate | -- | 13.5M | 30M | 42.43M |
High Estimate | -- | 13.5M | 107.2M | 180.3M |
Year Ago Sales | -- | -- | -- | 68.6M |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 56.82% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
NRXPW | -- | -- | -- | -- |
S&P 500 | 13.13% | 2.41% | 7.55% | 14.06% |
Related Tickers
RLFTF Relief Therapeutics Holding SA
2.8100
+1.26%
MEOBF Mesoblast Limited
0.9600
-33.33%
ADXS Ayala Pharmaceuticals, Inc.
0.1203
+281.30%
1541.HK IMMUNEONCO-B
13.240
-5.16%
BCTXW BriaCell Therapeutics Corp.
0.0750
-3.85%
BIOS.BR BioSenic S.A.
0.0021
0.00%
AGNPF Algernon Pharmaceuticals Inc.
0.0610
-8.68%
HAVLF HAVN Life Sciences Inc.
0.0005
0.00%
PXMD PaxMedica, Inc.
0.0001
0.00%
IVBXF Innovent Biologics, Inc.
10.13
0.00%